Recurrent Anaplastic Large Cell Lymphoma

11 clinical trials · Condition

Record	Firm	Date
Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas (NCT04074746)	M.D. Anderson Cancer Center	2020-07-18
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998)	City of Hope Medical Center	2019-02-04
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782)	M.D. Anderson Cancer Center	2017-11-14
Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (NCT03075553)	Mayo Clinic	2017-05-17
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma (NCT03017820)	Mayo Clinic	2017-04-04
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT01590732)	M.D. Anderson Cancer Center	2012-10-29
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01028716)	Fred Hutchinson Cancer Center	2010-05-19
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma (NCT01035463)	University of Nebraska	2009-11-12

Every clearance here is in the API, with alerts when new ones post.